Product category:
Chemicals and biochemicals
News Release from: Millipore | Subject: AdenoSilence vectors
Edited by the Laboratorytalk Editorial
Team on 06 December 2006
Millipore releases AdenoSilence vectors
for RNAi
Millipore has announced the launch of the first round of adenoviral shRNA expression vector reagents targeting the human druggable genome
The classes that are included in this release represent all the major protein classes amenable to small molecule intervention, including kinases, GPCRs, ion channels, proteases, nuclear hormone receptors, secreted proteins and receptors The targets were chosen to complement Millipore's current offering of drug discovery-based products and services
This article was originally published on Laboratorytalk on 3 Jul 2008 at 8.00am (UK)
Related stories
Stainless bins for disposable process containers
Mobius stainless steel bins provide support for handling disposable process containers filled with media, buffer, additional intermediates as well as final products
In vivo monitoring of stem cell behaviour
Millipore has announced the availability of its MilliTrace primary rodent neural stem cell (NSC) lines that express green fluorescent protein (GFP) constitutively
These AdenoSilence vectors are available in three different sequence variants sold individually or as a kit containing all three variants.
A replication incompetent version of the human adenovirus is used to introduce shRNA into a broad range of primary cells that decrease the expression of the targeted genes.
Human primary cells are the best systems to model disease and work well in target discovery programs.
AdenoSilence vectors allow for single step delivery of shRNA through the direct application of the virus supernatants onto a primary cell culture, thereby making any additional transfection reagents or complex transfection protocols unnecessary.
AdenoSilence reagents are highly efficient and typically silence the gene of interest for more than 10 days.
This extended knockdown duration supports longer-term assay protocols, such as differentiation assays, and simplifies the scheduling of assay runs.
This product is a result of a distribution agreement announced earlier this year between Millipore and BioFocus DPI, the drug discovery service division of Galapagos.
Millipore provides complete solutions for RNAi experimentation by offering products to deliver the RNAi reagent, measure the knockdown, and analyse the downstream effects with functional assays.
Millipore's Bioscience division provides innovative tools, services and application expertise in the pharmaceutical, academic, life science, applied science, clinical and government research sectors.
Its broad range of solutions for drug discovery, lab water, research reagents and sample preparation/biotools help customers improve laboratory productivity and efficiency through optimised workflows. Request a free brochure from Millipore ...
• Millipore: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
